🇺🇸 FDA
Patent

US 7569542

Anti-microbial targeting chimeric pharmaceutical

granted A61KA61K2039/505A61K47/6809

Quick answer

US patent 7569542 (Anti-microbial targeting chimeric pharmaceutical) held by The Regents of the University of California expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K47/6809, A61K47/6811, A61K47/6835